Share
Export Citation
Effectiveness of injectable platelet-rich fibrin (I-PRF) as a sole therapy in temporomandibular joint internal derangement with reduction: A systematic review
Nursanti N.
Cranio Journal of Craniomandibular and Sleep Practice
Q2Abstract
OBJECTIVE: Temporomandibular joint internal derangement with reduction commonly causes pain, joint clicking, and limited jaw movement. Injectable platelet-rich fibrin (I-PRF), an autologous concentrate containing growth factors, has emerged as a potential regenerative treatment. METHODS: This systematic review assessed the effectiveness of intra-articular I-PRF as a sole therapy for temporomandibular disorders (TMD). A literature search of PubMed, Scopus, Embase, and Web of Science (2015-2025) identified five eligible studies following PRISMA guidelines. RESULTS AND DISCUSSION: Included studies reported reduced pain, improved mouth opening, and decreased joint sounds after I-PRF therapy, without significant adverse effects. However, variations in study design and treatment protocols were noted. CONCLUSION: Overall, current evidence indicates that I-PRF may improve symptoms and jaw function as a minimally invasive conservative treatment for TMD. Nonetheless, the evidence remains limited due to methodological heterogeneity and the predominance of non-randomized studies, highlighting the need for further high-quality randomized controlled trials.